Lyme Disease clinical trials

Explore recruiting lyme disease clinical trials.

Recruiting lyme disease studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Lyme Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

C4601003 - A PHASE 3, MULTICENTER, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLINDED TRIAL TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY, AND LOT CONSISTENCY OF A 6-VALENT OSPA-BASED LYME DISEASE VACCINE IN HEALTHY PARTICIPANTS ≥5 YEARS OF AGE

Sweden, Netherlands, Poland, Finland, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Lyme Disease trials by city

Lyme Disease in Toronto Lyme Disease in Vancouver Lyme Disease in Montreal Lyme Disease in Calgary Lyme Disease in Edmonton Lyme Disease in Ottawa Lyme Disease in Winnipeg Lyme Disease in Quebec City Lyme Disease in Hamilton Lyme Disease in Kitchener Lyme Disease in London Lyme Disease in Halifax Lyme Disease in New York Lyme Disease in Los Angeles Lyme Disease in Chicago Lyme Disease in Houston

Lyme Disease clinical trials

Recruiting lyme disease studies right now

Human Immune Response to Ixodes Scapularis Tick Bites

Effectiveness of an Intervention Combining Adapted Physical Activity and Therapeutic Education in Patients With Chronic Symptoms Attributed to Lyme Borreliosis.

Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1982 to Prevent Lyme Disease in Healthy Participants (18 to 70 Years of Age)

Patient's Pretreatment Expectations About Post-Lyme Symptoms

Transcranial Direct Current Stimulation for Post Treatment Lyme Disease

taVNS for Persistent Symptoms From Lyme Disease

Evaluation of Cortisone Treatment in Children With Acute Facial Nerve Palsy

64Cu-DOTATATE-PET for Lyme Neuroborreliosis

Sana Device for Post-Treatment Lyme Disease Syndrome Chronic Pain

A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine

Effect of Saccharomyces Boulardii CNCM I-745 on Gut Microbiota in Patients Undergoing Antibiotic Therapy (in the Context of Erythema Migrans (Early Skin Form of Lyme Borreliosis))

Also recruiting in Europe

C4601003 - A PHASE 3, MULTICENTER, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLINDED TRIAL TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY, IMMUNOGENICITY, AND LOT CONSISTENCY OF A 6-VALENT OSPA-BASED LYME DISEASE VACCINE IN HEALTHY PARTICIPANTS ≥5 YEARS OF AGE

Lyme Disease trials by city

Other conditions